![ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] logo](/_assets/images/ELO_Logo_4c.svg){kind=logo}
Meet the ELOCTATE Peers, hear their stories, and learn why they count on the bleed protection offered by ELOCTATE prophylaxis.
*Data on file. Waltham, MA; Bioverativ Therapeutics Inc., a Sanofi company.
Hear practical insights from ELOCTATE Peers on what to expect from in-person and tele-medicine appointments, how to remain active, and how to stay busy in the current environment.
Chayse counts on ELOCTATE for overall bleed protection. After all, Chayse knows while he keeps the rhythm going, he’s protected from bleeds.
see Chayse's story
Craig and his doctor chose prophy with ELOCTATE to protect his body and his joints from bleeds after treated on demand for decades.
see craig's story
Eloctate helps keep DJ's joints protected from bleeds as he drums to a rhythm.
see dj's story
Jonathan switched from ADVATE® to ELOCTATE.
see jonathan's story
Jenny wants to protect her son's joints from bleeds now, and as he gets older.
see their story
When it comes to joint bleed protection, Chet’s son Caleb gets the coverage he needs on the court.
see their story
Kenny keeps his body and joints protected from bleeds on the road with ELOCTATE.
see kenny's storyNote: Patient stories reflect the real-life experiences of persons diagnosed with hemophilia A who have been prescribed ELOCTATE and their caregivers. However, individual experiences may vary. Patient stories are not necessarily representative of what another person using ELOCTATE may experience. Talk to your healthcare provider about what's right for you.
The recommended starting regimen is 50 IU/kg every 4 days as directed by your doctor. In children under 6 years of age, the recommended starting regimen is 50 IU/kg administered twice weekly. The regimen can be adjusted based on your body's individual response.
ADVATE® [Antihemophilic Factor (Recombinant)] is a registered trademark of Baxalta Incorporated, a Takeda company.
*ELOCTATE has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.
Sanofi Genzyme Hemophilia Community Relations and Education (CoRe) Managers offer education to people living with hemophilia and their families. CoRe Managers provide information about living with hemophilia and treatment options. Use our handy CoRe Locator to find the CoRe team member nearest you.
You know you're leaving the ELOCTATE website?
If you're okay with that, we're okay with that.
Come back soon!
You’re being directed to the ELOCTATE Healthcare Professional website. If you’re okay with that, we’re okay with that.
Come back soon!
INDICATION ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.
Important Safety Information and Indication INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES
IMPORTANT SAFETY INFORMATION INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES
Do not use ELOCTATE if you have had an allergic reaction to it in the past. No use ELOCTATE si ha tenido una reacción alérgica a este en el pasado.
Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII. Informe a su proveedor de atención médica si tiene o ha tenido algún problema médico; toma algún medicamento, incluidos medicamentos recetados y de venta libre, suplementos o medicamentos a base de hierbas; tiene alergias; está en período de lactancia; está embarazada o tiene intención de quedar embarazada; o si le han indicado que tiene inhibidores (anticuerpos) del factor VIII.
INDICATION INDICACIONES
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery. ELOCTATE® es un medicamento inyectable que se usa para ayudar a controlar y prevenir la hemorragia en personas con hemofilia A (deficiencia congénita del factor VIII). Su proveedor de atención médica le podría recetar ELOCTATE cuando se opere.
Important Safety Information and Indication INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES
IMPORTANT SAFETY INFORMATION INFORMACIÓN DE SEGURIDAD
Do not use ELOCTATE if you have had an allergic reaction to it in the past. No use ELOCTATE si ha tenido una reacción alérgica a este en el pasado.
Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII. Informe a su proveedor de atención médica si tiene o ha tenido algún problema médico; toma algún medicamento, incluidos medicamentos recetados y de venta libre, suplementos o medicamentos a base de hierbas; tiene alergias; está en período de lactancia; está embarazada o tiene intención de quedar embarazada; o si le han indicado que tiene inhibidores (anticuerpos) del factor VIII.
Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives. Pueden producirse reacciones alérgicas con ELOCTATE. Llame a su proveedor de atención médica o busque tratamiento de emergencia inmediatamente si presenta alguno de los siguientes síntomas: dificultad para respirar, opresión en el pecho, hinchazón de la cara, erupciones o urticaria.
Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly. Su organismo también puede producir anticuerpos denominados “inhibidores” contra ELOCTATE, que pueden impedir que este actúe correctamente.
Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. Los efectos secundarios frecuentes adicionales de ELOCTATE son dolor de cabeza, erupciones, dolor articular, dolor muscular y malestar general.
If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk. Si tiene factores de riesgo para el desarrollo de coágulos sanguíneos anómalos en su cuerpo, como un catéter venoso permanente, es posible que el tratamiento con factor VIII aumente este riesgo.
These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE. Estos no son todos los efectos secundarios posibles de ELOCTATE. Hable inmediatamente con su proveedor de atención médica sobre cualquier efecto secundario que le moleste o persista, o si la hemorragia no se controla después de usar ELOCTATE.
INDICATION INDICACIONES
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery. ELOCTATE® es un medicamento inyectable que se usa para ayudar a controlar y prevenir la hemorragia en personas con hemofilia A (deficiencia congénita del factor VIII). Su proveedor de atención médica le podría recetar ELOCTATE cuando se opere.
Please see Full Prescribing Information
CONSULTE LA INFORMACIÓN DE PRESCRIPCIÓN COMPLETA en inglés
POR FAVOR VER LA INFORMACIÓN DEPRESCRIPCIÓN COMPLETA en español
MANUFACTURED BY FABRICADO PARA
Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA Waltham, MA 02451 EE. UU.
U.S. License #2078 U.S. Licencia #2078
Click here to learn more about Sanofi's commitment to fighting counterfeit drugs. HAGA CLIC AQUÍ PARA OBTENER MÁS INFORMACIÓN SOBRE EL COMPROMISO DE SANOFI PARA COMBATIR LOS MEDICAMENTOS FALSIFICADOS.
![ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] logo](/_assets/images/elo-logo.svg){kind=logo}
Education Managers